Department of Pharmaceutics, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Sugitani 2630, Toyama 930-0194, Japan.
Department of Pharmaceutics, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Sugitani 2630, Toyama 930-0194, Japan.
J Control Release. 2022 Mar;343:434-442. doi: 10.1016/j.jconrel.2022.01.037. Epub 2022 Jan 29.
Since it has been known that in vitro cell lines for analyzing drug transport at the inner blood-retinal barrier (BRB) do not completely retain several in vivo functions, new ex vivo/in vitro methods to evaluate drug transport across the inner BRB help us understand the role of this barrier in maintaining the homeostasis of vision and regulating drug distribution to the retina. To expand the limitations of existing in vitro approaches, we established a protocol to isolate fresh rat retinal capillaries as ex vivo model of the inner BRB. Fresh retinal capillaries were prepared by applying serial filtration steps and using density gradient centrifugation. We performed mRNA and protein analyses by reverse transcription-polymerase chain reaction and immunostaining that indicated expression of marker proteins such as facilitative glucose transporter 1 and claudin-5 in freshly isolated rat retinal capillaries. We also used fluorescent transporter substrates to characterize functional activity of organic anion transporter (Oat) 3, P-glycoprotein (P-gp), breast cancer resistance protein (Bcrp), and multidrug resistance-associated protein (Mrp) 4 in isolated retinal capillaries. Capillary luminal accumulation of fluorescent substrates of P-glycoprotein and Bcrp was decreased in the presence of transporter inhibitors. Moreover, luminal accumulation of the Oat3 and Mrp4 substrate, 8-(2-[fluoresceinyl]aminoethylthio) adenosine-3',5'-cyclic monophosphate (8-[fluo]-cAMP), was reduced by substrates/inhibitors of Oat3 and Mrp4. In conclusion, our study shows that freshly isolated retinal capillaries retain marker protein expression and transporter functional activity. It is suggested that isolated retinal capillaries are a useful tool to study transport across the inner BRB. Using freshly isolated retinal capillaries, we anticipate applying this approach to determine the role of transporters at the inner BRB during pathophysiological states of the eye and evaluate the drug delivery to the retina.
由于已知用于分析内血视网膜屏障 (BRB) 药物转运的体外细胞系不完全保留几种体内功能,因此新的离体/体外方法来评估药物穿过内 BRB 的转运有助于我们了解该屏障在维持视力的体内平衡和调节药物向视网膜分布中的作用。为了扩大现有体外方法的局限性,我们建立了一种从新鲜大鼠视网膜毛细血管中分离的方法,作为内 BRB 的体外模型。通过应用连续过滤步骤和密度梯度离心法从新鲜视网膜毛细血管中分离。我们通过逆转录聚合酶链反应和免疫染色进行 mRNA 和蛋白质分析,表明在新鲜分离的大鼠视网膜毛细血管中表达了葡萄糖转运蛋白 1 和紧密连接蛋白 5 等标记蛋白。我们还使用荧光转运体底物来表征有机阴离子转运蛋白 (Oat) 3、P 糖蛋白 (P-gp)、乳腺癌耐药蛋白 (Bcrp) 和多药耐药相关蛋白 (Mrp) 4 在分离的视网膜毛细血管中的功能活性。在转运体抑制剂存在的情况下,荧光底物 P-糖蛋白和 Bcrp 的毛细血管腔积聚减少。此外,Oat3 和 Mrp4 底物 8-(2-[荧光素基]乙硫基)腺苷-3',5'-环单磷酸 (8-[fluo]-cAMP) 的腔积聚减少,通过 Oat3 和 Mrp4 的底物/抑制剂。总之,我们的研究表明,新鲜分离的视网膜毛细血管保留标记蛋白表达和转运体功能活性。建议分离的视网膜毛细血管是研究内 BRB 转运的有用工具。使用新鲜分离的视网膜毛细血管,我们预计将这种方法应用于确定在眼睛的病理生理状态下,内 BRB 转运体的作用,并评估药物向视网膜的输送。